Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Receivables: 2009-2025

Historic Receivables for INNOVATE (VATE) over the last 15 years, with Sep 2025 value amounting to $346.4 million.

  • INNOVATE's Receivables rose 13.72% to $346.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 4.53%. This contributed to the annual value of $300.3 million for FY2024, which is 24.36% down from last year.
  • Latest data reveals that INNOVATE reported Receivables of $346.4 million as of Q3 2025, which was up 6.36% from $325.7 million recorded in Q2 2025.
  • INNOVATE's 5-year Receivables high stood at $839.6 million for Q3 2021, and its period low was $279.4 million during Q2 2024.
  • In the last 3 years, INNOVATE's Receivables had a median value of $346.4 million in 2025 and averaged $387.7 million.
  • In the last 5 years, INNOVATE's Receivables soared by 85.64% in 2021 and then slumped by 52.07% in 2024.
  • Quarterly analysis of 5 years shows INNOVATE's Receivables stood at $483.6 million in 2021, then decreased by 13.15% to $420.0 million in 2022, then declined by 5.48% to $397.0 million in 2023, then declined by 24.36% to $300.3 million in 2024, then rose by 13.72% to $346.4 million in 2025.
  • Its Receivables was $346.4 million in Q3 2025, compared to $325.7 million in Q2 2025 and $299.8 million in Q1 2025.